A Potential Biomarker in Amyotrophic Lateral Sclerosis: Can Assessment of Brain Iron Deposition with SWI and Corticospinal Tract Degeneration with DTI Help?

References

1. 1.↵
   2. Langkammer C,
   3. Enzinger C,
   4. Quasthoff S, et al

   . Mapping of iron deposition in conjunction with assessment of nerve fiber tract integrity in amyotrophic lateral sclerosis. J Magn Reson Imaging 2010;31:1339–45 doi:10.1002/jmri.22185 pmid:20512885

   CrossRefPubMed
2. 2.↵
   2. Kiernan MC,
   3. Vucic S,
   4. Cheah BC, et al

   . Amyotrophic lateral sclerosis. Lancet 2011;377:942–55 doi:10.1016/S0140-6736(10)61156-7 pmid:21296405

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Petri S,
   3. Körner S,
   4. Kiaei M

   . Nrf2/ARE signaling pathway: key mediator in oxidative stress and potential therapeutic target in ALS. Neurol Res Int 2012;2012:878030 doi:10.1155/2012/878030 pmid:23050144

   CrossRefPubMed
4. 4.↵
   2. Jomova K,
   3. Vondrakova D,
   4. Lawson M, et al

   . Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem 2010;345:91–104 doi:10.1007/s11010-010-0563-x pmid:20730621

   CrossRefPubMed
5. 5.↵
   2. Toosy AT,
   3. Werring DJ,
   4. Orrell RW, et al

   . Diffusion tensor imaging detects corticospinal tract involvement at multiple levels in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2003;74:1250–57 doi:10.1136/jnnp.74.9.1250 pmid:12933929

   Abstract/FREE Full Text
6. 6.↵
   2. Aoki S,
   3. Iwata NK,
   4. Masutani Y, et al

   . Quantitative evaluation of the pyramidal tract segmented by diffusion tensor tractography: feasibility study in patients with amyotrophic lateral sclerosis. Radiat Med 2005;23:195–99 pmid:15940067

   PubMed
7. 7.↵
   2. Oshiro S,
   3. Morioka MS,
   4. Kikuchi M

   . Dysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Adv Pharmacol Sci 2011;2011:378278 doi:10.1155/2011/378278 pmid:22013437

   CrossRefPubMed
8. 8.↵
   2. Péran P,
   3. Hagberg G,
   4. Luccichenti G, et al

   . Voxel-based analysis of R2* maps in the healthy human brain. J Magn Reson Imaging 2007;26:1413–20 doi:10.1002/jmri.21204 pmid:18059009

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Jensen JH,
   3. Szulc K,
   4. Hu C, et al

   . Magnetic field correlation as a measure of iron-generated magnetic field inhomogeneities in the brain. Magn Reson Med 2009;61:481–85 doi:10.1002/mrm.21823 pmid:19161168

   CrossRefPubMed
10. 10.↵
    2. Bartzokis G,
    3. Tishler TA,
    4. Lu PH, et al

    . Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging 2007;28:414–23 doi:10.1016/j.neurobiolaging.2006.02.005 pmid:16563566

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Harder SL,
    3. Hopp KM,
    4. Ward H, et al

    . Mineralization of the deep gray matter with age: a retrospective review with susceptibility-weighted MR imaging. AJNR Am J Neuroradiol 2008;29:176–83 doi:10.3174/ajnr.A0770 pmid:17989376

    Abstract/FREE Full Text
12. 12.↵
    2. Yu J,
    3. Qi F,
    4. Wang N, et al

    . Increased iron level in motor cortex of amyotrophic lateral sclerosis patients: an in vivo MR study. Amyotroph Lateral Scler Frontotemporal Degener 2014;15:357–61 doi:10.3109/21678421.2014.906618 pmid:24809595

    CrossRefPubMed
13. 13.↵
    2. Haacke EM,
    3. Xu Y,
    4. Cheng YC, et al

    . Susceptibility weighted imaging (SWI). Magn Reson Med 2004;52:612–28 doi:10.1002/mrm.20198 pmid:15334582

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Haacke EM,
    3. Ayaz M,
    4. Khan A, et al

    . Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J Magn Reson Imaging 2007;26:256–64 doi:10.1002/jmri.22987 pmid:17654738

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Haacke EM,
    3. Makki M,
    4. Ge Y, et al

    . Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging 2009;29:537–44 doi:10.1002/jmri.21676 pmid:19243035

    CrossRefPubMed
16. 16.↵
    2. Wu SF,
    3. Zhu ZF,
    4. Kong Y, et al

    . Assessment of cerebral iron content in patients with Parkinson's disease by the susceptibility-weighted MRI. Eur Rev Med Pharmacol Sci 2014;18:2605–08 pmid:25317792

    PubMed
17. 17.↵
    2. Adachi Y,
    3. Sato N,
    4. Saito Y, et al

    . Usefulness of SWI for the detection of iron in the motor cortex in amyotrophic lateral sclerosis. J Neuroimaging 2015;25:443–51 doi:10.1111/jon.12127 pmid:24888543

    CrossRefPubMed
18. 18.↵
    2. Thomas B,
    3. Somasundaram S,
    4. Thamburaj K, et al

    . Clinical applications of susceptibility weighted MR imaging of the brain: a pictorial review. Neuroradiology 2008;50:105–16 doi:10.1007/s00234-007-0316-z pmid:17929005

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Brooks BR

    . El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis: Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors. J Neurol Sci 1994;124(suppl):96–107 doi:10.1016/0022-510X(94)90191-0 pmid:7807156

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Chiò A,
    3. Calvo A,
    4. Moglia C, et al

    . Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 2011;82:740–46 doi:10.1136/jnnp.2010.235952 pmid:21402743

    Abstract/FREE Full Text
21. 21.↵
    2. Roche JC,
    3. Rojas-Garcia R,
    4. Scott KM, et al

    . A proposed staging system for amyotrophic lateral sclerosis. Brain 2012;135:847–852 doi:10.1093/brain/awr351 pmid:22271664

    Abstract/FREE Full Text
22. 22.↵
    2. Hirayama K,
    3. Tsubaki T,
    4. Toyokura Y, et al

    . The representation of the pyramidal tract in the internal capsule and basis pedunculi: a study based on three cases of amyotrophic lateral sclerosis. Neurology 1962;12:337–42 doi:10.1212/WNL.12.5.337 pmid:13907643

    FREE Full Text
23. 23.↵
    2. Zhou B,
    3. Li S,
    4. Huijin H, et al

    . The evaluation of iron content in Alzheimer's disease by magnetic resonance imaging: phase and R2* methods. Adv Alzheimer Dis 2013;2:51–59 doi:10.4236/aad.2013.22007

    CrossRef
24. 24.↵
    2. Ropele S,
    3. de Graaf W,
    4. Khalil M, et al

    . MRI assessment of iron deposition in multiple sclerosis. J Magn Reson Imaging 2011;34:13–21 doi:10.1002/jmri.22590 pmid:21698703

    CrossRefPubMed
25. 25.↵
    2. Zecca L,
    3. Youdim MB,
    4. Riederer P, et al

    . Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004;5:863–73 doi:10.1038/nrn1537 pmid:15496864

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Kwan JY,
    3. Jeong SY,
    4. Van Gelderen P, et al

    . Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 Tesla MRI and pathology. PLoS One 2012;7:e35241 doi:10.1371/journal.pone.0035241 pmid:22529995

    CrossRefPubMed
27. 27.↵
    2. Oba H,
    3. Araki T,
    4. Ohtomo K, et al

    . Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology 1993;189:843–46 doi:10.1148/radiology.189.3.8234713 pmid:8234713

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Cheung G,
    3. Gawel MJ,
    4. Cooper PW, et al

    . Amyotrophic lateral sclerosis: correlation of clinical and MR imaging findings. Radiology 1995;194:263–70 doi:10.1148/radiology.194.1.7997565 pmid:7997565

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Hofmann E,
    3. Ochs G,
    4. Pelzl A, et al

    . The corticospinal tract in amyotrophic lateral sclerosis: an MRI study. Neuroradiology 1998;40:71–75 doi:10.1007/s002340050543 pmid:9541915

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Hecht MJ,
    3. Fellner F,
    4. Fellner C, et al

    . MRI-FLAIR images of the head show corticospinal tract alterations in ALS patients more frequently than T2-, T1- and proton-density-weighted images. J Neurol Sci 2001;186:37–44 doi:10.1016/S0022-510X(01)00503-2 pmid:11412870

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Kato Y,
    3. Matsumura K,
    4. Kinosada Y, et al

    . Detection of pyramidal tract lesions in amyotrophic lateral sclerosis with magnetization-transfer measurements. AJNR Am J Neuroradiol 1997;18:1541–47 pmid:9296197

    Abstract
32. 32.↵
    2. Cudkowicz M,
    3. Qureshi M,
    4. Shefner J

    . Measures and markers in amyotrophic lateral sclerosis. NeuroRx 2004;1:273–83 doi:10.1602/neurorx.1.2.273 pmid:15717028

    Abstract/FREE Full Text
33. 33.↵
    2. Mitsumoto H,
    3. Ulug AM,
    4. Pullman SL, et al

    . Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology 2007;68:1402–10 doi:10.1212/01.wnl.0000260065.57832.87 pmid:17452585

    Abstract/FREE Full Text
34. 34.↵
    2. Iwata NK,
    3. Kwan JY,
    4. Danielian LE, et al

    . White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis. Brain 2011;134(pt 9):2642–55 doi:10.1093/brain/awr178 pmid:21798965

    Abstract/FREE Full Text
35. 35.↵
    2. Olsen MK,
    3. Roberds SL,
    4. Ellerbrock BR, et al

    . Disease mechanisms revealed by transcription profiling in SOD1–G93A transgenic mouse spinal cord. Ann Neurol 2001;50:730–40 doi:10.1002/ana.1252 pmid:11761470

    CrossRefPubMedWeb of Science
36. 36.↵
    2. Restagno G,
    3. Lombardo F,
    4. Ghiglione P, et al

    . HFE H63D polymorphism is increased in patients with amyotrophic lateral sclerosis of Italian origin. J Neurol Neurosurg Psychiatry 2007;78:327 doi:10.1136/jnnp.2006.092338 pmid:17308297

    FREE Full Text
37. 37.↵
    2. Jacob S,
    3. Finsterbusch J,
    4. Weishaupt JH, et al

    . Diffusion tensor imaging for long-term follow-up of corticospinal tract degeneration in amyotrophic lateral sclerosis. Neuroradiology 2003;45:598–600 doi:10.1007/s00234-003-1014-0 pmid:12904924

    CrossRefPubMedWeb of Science
38. 38.↵
    2. Wang S,
    3. Poptani H,
    4. Bilello M, et al

    . Diffusion tensor imaging in amyotrophic lateral sclerosis: volumetric analysis of the corticospinal tract. AJNR Am J Neuroradiol 2006;27:1234–38 pmid:16775271

    Abstract/FREE Full Text
39. 39.↵
    2. Hong YH,
    3. Lee KW,
    4. Sung JJ, et al

    . Diffusion tensor MRI as a diagnostic tool of upper motor neuron involvement in amyotrophic lateral sclerosis. J Neurol Sci 2004;227:73–78 doi:10.1016/j.jns.2004.08.014 pmid:15546594

    CrossRefPubMedWeb of Science
40. 40.↵
    2. Sage CA,
    3. Peeters RR,
    4. Görner A, et al

    . Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis. Neuroimage 2007;34:486–99 doi:10.1016/j.neuroimage.2006.09.025 pmid:17097892

    CrossRefPubMedWeb of Science